Sui Xiong Cai
Patrimonio netto: 39 M $ in data 30/06/2026
Patrimonio netto: 39 M $ in data 30/06/2026
Sui Xiong Cai is currently Chief Executive Officer & Executive Director at IMPACT Therapeutics, Inc., a position started in 2025.
Formerly, Dr. Cai was Senior Director-Chemistry at EpiCept Corp.
from 2006 to 2009.
Education includes a doctorate from the University of Oregon, conferred in 1990.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 10/06/2026 | 8.422.233 ( 2,98% ) | 39 M $ | 30/06/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| IMPACT THERAPEUTICS, INC | Amministratore Delegato | 01/06/2014 |
| Società | Posizione | Fine |
|---|---|---|
EpiCept Corp.
EpiCept Corp. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products for the treatment of cancer and pain | Corporate Officer/Principal | 01/01/2009 |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 3 |
|---|---|
University of Oregon
University of Oregon Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
EpiCept Corp.
EpiCept Corp. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products for the treatment of cancer and pain | Health Technology |
IMPACT Therapeutics, Inc.
IMPACT Therapeutics, Inc. BiotechnologyHealth Technology Operates as a commercial-stage biotechnology company that develops anti-cancer therapies and pharmaceutical products | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale